Ftse Mib
34.075,17
-0,87%
DAX
19.887,89
-0,58%
S&P 500
5.914,04
0,78%
NASDAQ
19.447,72
0,87%
Bitcoin
98.261,03
1,41%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. AMEX Cel Sci Corporation New (CVM) Cel Sci Corporation New (CVM) Notizie

Cel Sci Corporation New

CVM
0,4175
0,0026 (0,63%)
Ultimo aggiornamento: 17:09:52
Dati in Delay di 15 minuti
Borsa: AMEX
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/1/202520:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202520:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/1/202520:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/12/202422:15EDGAR2Form 8-K - Current report
31/12/202422:05BWCEL-SCI Announces Closing of $5 Million Offering
30/12/202423:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
30/12/202402:41BWCEL-SCI Announces Pricing of $5 Million Public Offering
27/12/202423:05BWCEL-SCI Announces Proposed Public Offering of Common Stock
12/12/202415:15BWCEL-SCI Highlights Biological Rationale for the Use of..
15/11/202422:30EDGAR2Form 8-K - Current report
13/11/202414:30EDGAR2Form 8-K - Current report
08/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
07/11/202414:15BWU.S. FDA and CEL-SCI Agree on Use of PD-L1 Biomarker to..
30/10/202422:21EDGAR2Form S-3/A - Registration statement under Securities Act of..
25/10/202423:17EDGAR2Form S-3 - Registration statement under Securities Act of..
22/10/202415:15BWFDA’s Oncologic Drugs Advisory Committee Decision on..
10/10/202422:05EDGAR2Form AW - Amendment Withdrawal Request
01/10/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202414:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202412:00BWCEL-SCI Selects Ergomed as CRO as it Gears Up for..
16/9/202413:30BWCEL-SCI’s Multikine® Increased 5-Year Survival Rate to 82.6%..
10/9/202415:32BWCEL-SCI to Present New Data for Multikine® Head & Neck..
04/9/202415:00BWThe UK’s Medicines & Healthcare Products Regulatory Agency..
30/8/202422:32EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/8/202414:00BWCEL-SCI Corporation Reports Third Quarter Fiscal 2024..
14/8/202422:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
29/7/202423:16EDGAR2Form 8-K - Current report
29/7/202422:05BWCEL-SCI Announces Closing of $10.8 Million Offering
26/7/202423:27EDGAR2Form 8-K - Current report
26/7/202417:52BWCEL-SCI Announces Pricing of $10.8 Million Offering
26/7/202414:23BWCEL-SCI’s Phase 3 Population Analysis for Upcoming..
08/7/202415:15BWCEL-SCI Appoints Robert Watson as Chairperson of the Board
18/6/202414:00BWCEL-SCI Presents Head & Neck Cancer Data at Iddst Annual..
06/6/202413:00BWDr. Giovanni Selvaggi, Who Has Brought Several Oncology..
16/5/202415:00BWCEL-SCI Corporation Reports Second Quarter Fiscal 2024..
15/5/202422:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202419:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202415:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202415:00BWCEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of..
23/4/202415:00BWCEL-SCI Appoints Mario Gobbo to Its Board of Directors
19/3/202414:00BWCEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to..
07/3/202417:33EDGAR2Form ARS - Annual Report to Security Holders
06/3/202414:45BWCEL-SCI Corporation Issues Letter to Shareholders
15/2/202414:00BWCEL-SCI Corporation Reports First Quarter Fiscal 2024..
14/2/202422:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/2/202418:00BWCEL-SCI Announces Closing of $7.75 Million Public Offering..
09/2/202414:30BWCEL-SCI Announces Pricing of $7.75 Million Public Offering..
06/2/202415:00BWCEL-SCI Completes Commissioning of Its Multikine..
Apertura: 0,4141 Min: 0,41 Max: 0,4246
Chiusura: 0,4149

La tua Cronologia

AMEX
CVM
Cel Sci
COIN
ZCRBTC
ZCore
BIT
JREJ
Japan Research Enhanced ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network